|
Aug 1
|
BioMarin Announces Appointment of Ian T. Clark to Board of Directors
|
|
Aug 1
|
Guardant Health Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Jul 31
|
Guardant Health to Participate in the Canaccord Genuity 45th Annual Growth Conference
|
|
Jul 31
|
Guardant Health Inc (GH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Raised ...
|
|
Jul 30
|
Guardant Health (GH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Jul 30
|
Guardant Health (NASDAQ:GH) Beats Expectations in Strong Q2, Guides for Strong Full-Year Sales
|
|
Jul 30
|
Guardant Health (GH) Reports Q2 Loss, Beats Revenue Estimates
|
|
Jul 30
|
Guardant Health: Q2 Earnings Snapshot
|
|
Jul 30
|
Guardant Health Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
|
|
Jul 30
|
Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+
|
|
Jul 29
|
Tempus AI Taps Growing ICI Market With New xM Assay
|
|
Jul 29
|
New RADIOHEAD Study Validates Use of Guardant Reveal Tissue-Free Monitoring for Earlier Detection of Immunotherapy Response in Advanced Cancer
|
|
Jul 29
|
Guardant Health (GH) Q2 Earnings: What To Expect
|
|
Jul 24
|
Cathie Wood's Bold AI and Genomics Playbooks Revealed
|
|
Jul 24
|
Cathie Wood Pours Millions into Nvidia and Biotech, Dumps Rocket Lab
|
|
Jul 23
|
Guardant Health (NASDAQ:GH investor five-year losses grow to 44% as the stock sheds US$228m this past week
|
|
Jul 23
|
3 Reasons to Avoid GH and 1 Stock to Buy Instead
|
|
Jul 22
|
1 Volatile Stock to Own for Decades and 2 We Brush Off
|
|
Jun 30
|
The 5 Most Interesting Analyst Questions From Guardant Health’s Q1 Earnings Call
|
|
Jun 25
|
The Top 5 Analyst Questions From Guardant Health’s Q1 Earnings Call
|